343 related articles for article (PubMed ID: 15577103)
1. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
Sakaguchi T; Akizawa T
Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
[TBL] [Abstract][Full Text] [Related]
2. [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
Orita H; Akizawa T
Clin Calcium; 2004 May; 14(5):693-7. PubMed ID: 15577029
[TBL] [Abstract][Full Text] [Related]
3. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.
Bailie GR; Massry SG;
Pharmacotherapy; 2005 Dec; 25(12):1687-707. PubMed ID: 16305288
[TBL] [Abstract][Full Text] [Related]
4. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
Inaguma D; Tatematsu M
Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
[TBL] [Abstract][Full Text] [Related]
5. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
6. Difficulties in achieving the K/DOQI practice guidelines for bone and mineral metabolism.
González EA; Al-Aly Z; Martin KJ
Semin Dial; 2005; 18(3):171-4. PubMed ID: 15934956
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
Ito H; Kinugasa E
Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
[TBL] [Abstract][Full Text] [Related]
8. [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].
Akiba T
Clin Calcium; 2009 Apr; 19(4):537-44. PubMed ID: 19329833
[TBL] [Abstract][Full Text] [Related]
9. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications.
Uribarri J;
Semin Dial; 2004; 17(5):349-50. PubMed ID: 15461740
[TBL] [Abstract][Full Text] [Related]
10. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
[TBL] [Abstract][Full Text] [Related]
11. Bone metabolism and disease--K/DOQI impact on nurses and dietitians.
Knapp S
Nephrol Nurs J; 2004; 31(3):333-5. PubMed ID: 15303430
[TBL] [Abstract][Full Text] [Related]
12. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
Hoy T; Fisher M; Barber B; Borker R; Stolshek B; Goodman W
Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
[TBL] [Abstract][Full Text] [Related]
13. Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?
Gal-Moscovici A; Sprague SM; Hutchison AJ; Shah N; Piraino B; Cunningham J
Semin Dial; 2007; 20(1):24-32. PubMed ID: 17244115
[No Abstract] [Full Text] [Related]
14. [Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Tokumoto T; Tanabe K; Toma H; Akiba T
Clin Calcium; 2004 May; 14(5):710-8. PubMed ID: 15577031
[TBL] [Abstract][Full Text] [Related]
15. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
Yaginuma T; Yamamoto H
Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
[TBL] [Abstract][Full Text] [Related]
16. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
[TBL] [Abstract][Full Text] [Related]
17. Adherence to K/DOQI bone metabolism guidelines.
Smith DH; Johnson ES; Thorp ML; Yang X
J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
[TBL] [Abstract][Full Text] [Related]
18. Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
Monge M; Shahapuni I; Oprisiu R; El Esper N; Morinière P; Massy Z; Choukroun G; Fournier A
Nat Clin Pract Nephrol; 2006 Jun; 2(6):326-36. PubMed ID: 16932454
[TBL] [Abstract][Full Text] [Related]
19. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
20. Adherence to K/DOQI guidelines for calcium-based phosphate binders in clinical practice.
Shastri J; Tran A; Covit A; Pepe J; Sherman RA
J Ren Nutr; 2008 Jul; 18(4):370-4. PubMed ID: 18558302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
